Why is Krebs Biochem falling/rising?

As of 14-Jul, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 80.52, which reflects a decrease of Rs 1.74 or 2.12%. The stock has underperformed its sector by 3.02% today and has shown erratic trading patterns, not trading on one day out of the last 20. It has also touched an intraday low of Rs 80, indicating bearish sentiment. Over the past week, the stock has dropped by 6.37%, and its performance over the last month shows a decline of 9.22%. The company has reported negative results for the last two consecutive quarters, with a negative book value and a high debt-to-equity ratio, contributing to its weak long-term fundamental strength. Additionally, the delivery volume has significantly decreased, suggesting falling investor participation.
In the broader market context, Krebs Biochemicals has consistently underperformed against the benchmark, with a year-to-date return of -12.95% compared to the Sensex's gain of 5.27%. This trend of underperformance has been evident over the last three years, where the stock has generated negative returns while the benchmark has seen substantial growth. The company's weak financial performance, characterized by declining profits and a negative EBITDA, further exacerbates its struggles in the market, leading to a lack of investor confidence and contributing to the stock's downward trajectory.